Applications & Industry Solutions

---

Databite AI develops computational systems intended to support:

• Pharmaceutical research 
• Molecular interaction analysis 
• Therapeutic candidate evaluation 
• Structural bioinformatics 
• Oncology research pipelines

Traditional drug discovery often involves:

• Years of laboratory testing 
• Massive research cost 
• Large experimental failure rates 
• Extensive screening processes 

AI-assisted systems help researchers:

• Prioritize targets 
• Analyze structural compatibility 
• Simulate molecular interactions 
• Predict biological behavior 
• Reduce early-stage discovery complexity

Databite AI’s research systems may assist with:

• Tumor signaling analysis 
• Mutation pathway modeling 
• Therapeutic target identification 
• Protein interaction mapping 
• Drug resistance analysis

Databite AI aims to collaborate with:

• Pharmaceutical companies 
• Biotechnology firms 
• Research laboratories 
• Computational biology institutions 
• AI research organizations 

Potential partnership areas include:

• Molecular simulation 
• AI-assisted screening 
• Biological interaction analysis 
• Therapeutic pathway modeling 
• Computational oncology research

We believe future AI-biological systems may contribute to:

• Precision medicine 
• Personalized therapeutics 
• AI-assisted diagnostics 
• Predictive oncology 
• Dynamic cellular simulation 
• Advanced therapeutic modeling